Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patients-Reference-Cited by-同舟云学术

Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patients

Published:2019-02-20 Issue:1 Volume:12 Page:
ISSN:1757-2215
Container-title:Journal of Ovarian Research
language:en
Short-container-title:J Ovarian Res

Author:

Zhang Lei,Luo Min,Yang Hongying,Zhu Shaoyan,Cheng Xianliang,Qing Chen

Funder

National Natural Science Foundation of China

Yunnan Provincial Science and Technology Department

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13048-019-0494-4.pdf

Reference44 articles.

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71–96.

2. Cannistra SA. Cancer of the ovary. N Engl J Med. 2004;351(24):2519–29.

3. Bhoola S, Hoskins WJ. Diagnosis and management of epithelial ovarian cancer. Obstet Gynecol. 2006;107(6):1399–410.

4. Piccart MJ, Bertelsen K, Stuart G, Cassidy J, Mangioni C, Simonsen E, et al. Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. Int J Gynecol Cancer. 2003;13(Suppl 2):144–8.

5. Cress RD, Chen YS, Morris CR, Petersen M, Leiserowitz GS. Characteristics of long-term survivors of epithelial ovarian Cancer. Obstet Gynecol. 2015;126(3):491–7.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant Human Adenovirus Type 5 (H101) Intra-Tumor Therapy in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer: Genomic Profiling Relating to Clinical Efficacy;Drug Design, Development and Therapy;2023-11

2. Regulatory network and targeted interventions for CCDC family in tumor pathogenesis;Cancer Letters;2023-07

3. Social, Genetics and Histopathological Factors Related to Titin (TTN) Gene Mutation and Survival in Women with Ovarian Serous Cystadenocarcinoma: Bioinformatics Analysis;Genes;2023-05-16

4. Comprehensive Analysis of Purine-Metabolism-Related Gene Signature for Predicting Ovarian Cancer Prognosis, Immune Landscape, and Potential Treatment Options;Journal of Personalized Medicine;2023-04-29

5. CWAOMT: Class Weight balanced Artificial Neural Network model for the Classification of Ovarian Malignancy from Transcriptomic Profiles;2023 International Conference on Networking and Communications (ICNWC);2023-04-05